![Global Therapeutic Vaccines Market](https://res.cloudinary.com/devmoveo/image/upload/v1715066986/skyquest/gallery/Global-Therapeutic-Vaccines-Market.jpg)
Report ID: SQMIG35J2111
Report ID:
SQMIG35J2111 |
Region:
Global |
Published Date: May, 2024
Pages:
215
|
Tables:
95 |
Figures:
78
Global Therapeutic Vaccines Market size was valued at USD 25.7 billion in 2022 and is poised to grow from USD 53.71 billion in 2023 to USD 119.39 billion by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).
Therapeutic vaccines are given to the patient undergoing treatment from disease to strengthen immune response and promote better recovery. Growing use of therapeutic vaccine to improve the chances of successful treatment of patients affected with chronic diseases is driving market growth, High incidence of chronic diseases and rising investments in R&D of novel vaccines are also forecasted to benefit sales of therapeutic vaccine in the future. Rising awareness regarding preventive healthcare and growing demand for personalized medicine around the world are also estimated to boost the demand for therapeutic vaccine over the coming years. On the contrary, complexity in research and development process and limited efficacy are projected to be key restraints for therapeutic vaccine market development in the long run. Therapeutic vaccine companies can open up new avenues of opportunities by integrating their products with different immunotherapies and precision medicine going forward.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2111